Your browser doesn't support javascript.
loading
Impact of gene-by-trauma interaction in MDD-related multimorbidity clusters.
Bonk, Sarah; Eszlari, Nora; Kirchner, Kevin; Gezsi, Andras; Garvert, Linda; Kuokkanen, Mikko; Cano, Isaac; Grabe, Hans J; Antal, Peter; Juhasz, Gabriella; Van der Auwera, Sandra.
Affiliation
  • Bonk S; Department of Psychiatry and Psychotherapy, University Medicine Greifswald, 17475 Greifswald, Germany.
  • Eszlari N; Department of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, Nagyvárad tér 4., H-1089 Budapest, Hungary; NAP3.0-SE Neuropsychopharmacology Research Group, Hungarian Brain Research Program, Semmelweis University, Ülloi út 26., H-1085 Budapest, Hungary.
  • Kirchner K; Department of Psychiatry and Psychotherapy, University Medicine Greifswald, 17475 Greifswald, Germany.
  • Gezsi A; Department of Measurement and Information Systems, Budapest University of Technology and Economics, Muegyetem rkp. 3., H-1111 Budapest, Hungary.
  • Garvert L; Department of Psychiatry and Psychotherapy, University Medicine Greifswald, 17475 Greifswald, Germany.
  • Kuokkanen M; Department of Public Health and Welfare, Finnish Health and Welfare Institute. Biomedicum 1, Haartmaninkatu 8, 00290 Helsinki, Finland; Department of Human Genetics and South Texas Diabetes and Obesity Institute, School of Medicine at University of Texas Rio Grande Valley, Brownsville, TX, United St
  • Cano I; Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Villarroel 170, Barcelona 08036. Spain.
  • Grabe HJ; Department of Psychiatry and Psychotherapy, University Medicine Greifswald, 17475 Greifswald, Germany; German Centre for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, 17475 Greifswald, Germany.
  • Antal P; Department of Measurement and Information Systems, Budapest University of Technology and Economics, Muegyetem rkp. 3., H-1111 Budapest, Hungary.
  • Juhasz G; Department of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, Nagyvárad tér 4., H-1089 Budapest, Hungary; NAP3.0-SE Neuropsychopharmacology Research Group, Hungarian Brain Research Program, Semmelweis University, Ülloi út 26., H-1085 Budapest, Hungary.
  • Van der Auwera S; Department of Psychiatry and Psychotherapy, University Medicine Greifswald, 17475 Greifswald, Germany; German Centre for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, 17475 Greifswald, Germany. Electronic address: Sandra.auwera@uni-greifswald.de.
J Affect Disord ; 359: 382-391, 2024 Aug 15.
Article in En | MEDLINE | ID: mdl-38806065
ABSTRACT

BACKGROUND:

Major depressive disorder (MDD) is considerably heterogeneous in terms of comorbidities, which may hamper the disentanglement of its biological mechanism. In a previous study, we classified the lifetime trajectories of MDD-related multimorbidities into seven distinct clusters, each characterized by unique genetic and environmental risk-factor profiles. The current objective was to investigate genome-wide gene-by-environment (G × E) interactions with childhood trauma burden, within the context of these clusters.

METHODS:

We analyzed 77,519 participants and 6,266,189 single-nucleotide polymorphisms (SNPs) of the UK Biobank database. Childhood trauma burden was assessed using the Childhood Trauma Screener (CTS). For each cluster, Plink 2.0 was used to calculate SNP × CTS interaction effects on the participants' cluster membership probabilities. We especially focused on the effects of 31 candidate genes and associated SNPs selected from previous G × E studies for childhood maltreatment's association with depression.

RESULTS:

At SNP-level, only the high-multimorbidity Cluster 6 revealed a genome-wide significant SNP rs145772219. At gene-level, MPST and PRH2 were genome-wide significant for the low-multimorbidity Clusters 1 and 3, respectively. Regarding candidate SNPs for G × E interactions, individual SNP results could be replicated for specific clusters. The candidate genes CREB1, DBH, and MTHFR (Cluster 5) as well as TPH1 (Cluster 6) survived multiple testing correction.

LIMITATIONS:

CTS is a short retrospective self-reported measurement. Clusters could be influenced by genetics of individual disorders.

CONCLUSIONS:

The first G × E GWAS for MDD-related multimorbidity trajectories successfully replicated findings from previous G × E studies related to depression, and revealed risk clusters for the contribution of childhood trauma.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Single Nucleotide / Depressive Disorder, Major / Gene-Environment Interaction / Multimorbidity Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: J Affect Disord Year: 2024 Document type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Single Nucleotide / Depressive Disorder, Major / Gene-Environment Interaction / Multimorbidity Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: J Affect Disord Year: 2024 Document type: Article Affiliation country: Germany